Lv0
0 积分 2024-08-21 加入
Novel therapeutics and future directions for refractory immune thrombocytopenia
2小时前
已完结
Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: A systematic review and meta‐analysis
22天前
已完结
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
22天前
已完结
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
22天前
已完结
The potential of CD38 protein as a target for autoimmune diseases
2个月前
已完结
A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics
2个月前
已关闭
A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics
2个月前
已关闭
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
3个月前
已完结
LBA0007 SAFETY AND EFFICACY OF DARATUMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS – A SINGLE-CENTER PHASE 2 OPEN-LABEL TRIAL
3个月前
已完结
An updated advance of autoantibodies in autoimmune diseases
3个月前
已完结
皖公网安备34019202002308
